Syndome with combined immunodeficiency due to thymic defect

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:331220
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Syndrome with combined immunodeficiency due to thymic defect (Orphanet code 331220) is a group of rare primary immunodeficiency disorders in which the underlying cause of immune dysfunction is a developmental or functional abnormality of the thymus gland. The thymus is essential for the maturation and selection of T lymphocytes, and defects in thymic development lead to severely impaired T-cell immunity, often accompanied by secondary deficiency in B-cell function due to the lack of T-cell help. This results in combined immunodeficiency (CID), which affects the immune system's ability to fight infections. Patients typically present in infancy or early childhood with recurrent, severe, and often life-threatening infections, including bacterial, viral, fungal, and opportunistic infections. Additional features may include failure to thrive, chronic diarrhea, skin manifestations, and susceptibility to autoimmune complications. The severity of immunodeficiency can vary depending on the specific underlying genetic cause and the degree of thymic impairment. Some conditions within this category, such as DiGeorge syndrome (22q11.2 deletion syndrome) and FOXN1 deficiency, are well-characterized examples where thymic aplasia or hypoplasia is a central feature, though this Orphanet grouping encompasses a broader set of thymic defect-related combined immunodeficiencies. Management depends on the severity of the immune defect. Supportive care includes prophylactic antimicrobials, immunoglobulin replacement therapy, and aggressive treatment of infections. For severe cases with absent or profoundly deficient T-cell function, thymus transplantation has been used successfully in select centers, particularly for complete DiGeorge syndrome. Hematopoietic stem cell transplantation (HSCT) may also be considered in certain cases. Gene therapy approaches are under investigation for specific genetic forms. Early diagnosis through newborn screening programs that detect T-cell receptor excision circles (TRECs) has improved outcomes by enabling prompt intervention.

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Syndome with combined immunodeficiency due to thymic defect.

View clinical trials →

No actively recruiting trials found for Syndome with combined immunodeficiency due to thymic defect at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Syndome with combined immunodeficiency due to thymic defect community →

No specialists are currently listed for Syndome with combined immunodeficiency due to thymic defect.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Syndome with combined immunodeficiency due to thymic defect.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Syndome with combined immunodeficiency due to thymic defectForum →

No community posts yet. Be the first to share your experience with Syndome with combined immunodeficiency due to thymic defect.

Start the conversation →

Latest news about Syndome with combined immunodeficiency due to thymic defect

No recent news articles for Syndome with combined immunodeficiency due to thymic defect.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Syndome with combined immunodeficiency due to thymic defect

What is Syndome with combined immunodeficiency due to thymic defect?

Syndrome with combined immunodeficiency due to thymic defect (Orphanet code 331220) is a group of rare primary immunodeficiency disorders in which the underlying cause of immune dysfunction is a developmental or functional abnormality of the thymus gland. The thymus is essential for the maturation and selection of T lymphocytes, and defects in thymic development lead to severely impaired T-cell immunity, often accompanied by secondary deficiency in B-cell function due to the lack of T-cell help. This results in combined immunodeficiency (CID), which affects the immune system's ability to fight

At what age does Syndome with combined immunodeficiency due to thymic defect typically begin?

Typical onset of Syndome with combined immunodeficiency due to thymic defect is infantile. Age of onset can vary across affected individuals.